MAIN ARTICLE
Corporate earnings give the rally its shape
An index can rise for many reasons, but Thursday's movement had unusually tangible corporate catalysts. Aerospace and defence stocks gained 1.4%, according to Reuters, as Rolls-Royce advanced 2.8%. The engine maker reaffirmed its full-year outlook and unveiled a £1.5 billion share repurchase. A buyback can signal management's confidence in cash generation, although it is not a substitute for durable operating performance. Healthcare was another source of support: AstraZeneca rose 0.9% and GSK 1.1%, bringing the defensive qualities of established drug businesses into an otherwise cyclical rally.
The response to individual earnings announcements was more dramatic outside those heavyweight sectors. Burberry climbed 9.4% after reporting better-than-expected second-quarter sales and first-half profit. The company's emphasis on products at a range of price points appeared to resonate with consumers navigating luxury fatigue. In the FTSE 250, discount retailer B&M surged 18.3% after indicating that annual profit could grow by as much as 16%. Those moves showed that investors were rewarding credible evidence of improved demand and execution, even where household spending conditions remained difficult.

















